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Background: With the rapid aging of populations around the world, dementia has become one of the most
important public health problems in Eastern Asian countries. The purpose of the present study was to provide an
estimate of the burden of dementia and forecast its future burden, as generalized to the Korean population, and to
provide detailed gender- and age-specific information regarding the burden of dementia in the elderly population
of Korea.
Methods: ‘Disability-adjusted life years’ (DALYs) were used to estimate the burden of dementia. Epidemiologic data
from national statistics and nationwide epidemiologic studies in the year 2008 were used to obtain representative
outcomes for the Korean population. We estimated the DALYs due to dementia from the years 2010 to 2050 by
applying demographic structure projections in terms of 5-year age groups in Korea.
Results: The burden of disease due to dementia in Korea is 528 per 100,000 population (males: 435, females: 622)
and 5,117 per 100,000 in those over the age of 65 years (males: 5,228; females: 5,041); this accounts for 4.5% of the
total burden of disease in the year 2008. In the year 2050, DALYs due to dementia (814,629) are expected to be 3.0
times higher than those in the year 2010 (274,849).
Conclusion: Dementia has the highest burden of disease in the elderly Korean population, and this burden will
increase sharply with the aging of the population. More comprehensive and multi-dimensional approaches,
including clinical, psychological, social, and political means will be needed for the management of the dramatically
increasing burden of dementia.
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Dementia generally occurs in the elderly and is one of the
most serious mental illnesses in the Korean population [1].
Given its progressive, irreversible natural course, together
with its high prevalence in the elderly population, dementia
has one of the biggest burdens of disease in the elderly
[2,3]. As the world’s population is rapidly aging, dementia
has become an important public health problem [4,5].
The World Health Organization (WHO) has estimated de-
mentia to be the 11th leading cause of years lived with
disability (YLD) at a global level, accounting for 2.0% of
the total global YLDs [6]. By the year 2050, the worldwide* Correspondence: hkcheong@skku.edu
1Department of Social and Preventive Medicine, Sungkyunkwan University
School of Medicine, 2066 Seobu-ro, Jangan-gu, Suwon, Gyeonggi-do
440-746, Republic of Korea
2Center for Molecular Medicine, Samsung Biomedical Research Institute,
Seoul, Republic of Korea
© 2013 Park et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the orprevalence of dementia will quadruple to 106.2 million per-
sons, with 1 in 85 persons living with Alzheimer's disease
[7]. Specifically, dementia is expected to become a more of
a serious health and social burden in developing countries
than in developed countries. This is because unprece-
dented declines in mortality and fertility have resulted in a
rapid aging process in most developing countries [8],
which is exacerbated by poor health care facilities.
To estimate the burden of diseases, the WHO recom-
mends using disability-adjusted life years (DALYs) [9].
DALYs have the merit of simplicity and comprehensive-
ness, as its calculation produces a single number that
combines information on mortality and non-fatal health
outcomes. According to the Global Burden of Disease
(GBD) estimates from the 2003 World Health Report
[10], dementia contributed 11.2% of the YLD in people
aged 60 years and older. This is more than stroke (9.5%),. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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(5.0%), and all forms of cancer (2.4%).
These estimates have limitations because of the lack of
accurate epidemiologic data, especially in developing
countries [7]. In 2003, the World Health Report addressed
dementia in many world regions; however, such evidence
suffers from incompleteness or is limited in coverage.
Even when a wider evidence base is available for country-
or region-specific figures, these estimates are sometimes
generated from a single study with limited generalization.
Previous global estimates of the number of people with
dementia have tended to apply a uniform age-specific
prevalence, assuming no geographic variation [11,12].
However, prevalence has been noted to be lower in deve-
loping countries [13], strikingly so in some studies [14,15].
Korea represents an unique situation in terms of the
burden of dementia. Korea has a population of over 49
million people. Its life expectancy at birth has increased
dramatically in recent years (71.3 in 1990, 78.6 in 2000,
and 80.8 in 2010 [16]. The country is in the midst of a
rapid transition from being a low-income country to
becoming a high-income country, and its population
structure is aging at an unprecedented speed [16]. The
proportion of the elderly population reached 7.2% in
2000 and is expected to exceed 14% by 2018, and 20.8%
by 2026; one of the fastest transitions from an aging so-
ciety to an ultra-aged society. Therefore, changes in the
burden of disease due to dementia in Korea may repre-
sent a typical situation that will be experienced in many
developing countries in the near future.
A previous WHO study [17] estimated the burden of
dementia in Korea using several epidemiologic indices
adopted from other countries. These indices included inci-
dence and relative risk of mortality from European coun-
tries, where prevalence was consistent with literature for
Chinese populations due to the lack of epidemiologic data
from the Korean population. However, a recent study [18]
also did not use epidemiologic data produced in the
Korean population, but used meta-analysis results from
other high-income Asia Pacific countries instead. As such,
there is a critical need for a study to estimate the burden
of dementia using Korean-specific epidemiologic data.
This study was conducted to provide an estimate of the
burden of dementia in the elderly and to forecast it for
the future to provide detailed gender- and age-specific es-
timates of the burden of dementia using the most recent
epidemiologic data from the Korean population.
Methods
Data source and epidemiologic data
DALYs due to dementia were calculated using various
epidemiologic data such as incidence, prevalence, remis-
sion rate, case mortality, age of onset, disease duration,
disability weight, total mortality of the population, andpopulation structure. All the data were derived from vari-
ous epidemiologic studies conducted in Korea and from a
Korean national dataset [19]. This previous nationwide
population study carried out in 2008 was based on 8,199
probability-sampled Koreans aged 65 years or older. The
study used a 2-step assessment method to identify persons
with dementia: 1) All the sampled individuals were invited
to participate in the Phase I screening assessment using the
Mini-Mental State Examination via door-to-door home
visits, and 2) the Phase II diagnostic assessment for demen-
tia was administered using the Korean version of the Con-
sortium to Establish a Registry for Alzheimer’s Disease
Assessment Packet (CERAD-K) clinical assessment battery,
neuroimaging, including computed tomography or mag-
netic resonance imaging (MRI), and laboratory testing.
Patients were diagnosed with dementia using the criteria
established in the Diagnostic and Statistical Manual, 4th
Revision (DSM-IV), or with Alzheimer’s disease according
to the criteria of the National Institute of Neurological and
Communicative Disorders and Stroke and the Alzheimer’s
Disease and Related Disorders Association (NINCDS-
ADRDA), or with vascular dementia according to the cri-
teria of the National Institute of Neurologic Disorders and
Stroke/Association Internationale pour la Recherche et
l’Enseignement en Neurosciences (NINDS-AIREN) [19].
We adopted gender- and age-specific prevalence of demen-
tia for this study from the published article [19] and report
[20]. As the previous report used a sample aged 65 years or
older, we also adopted the prevalence of dementia in adults
aged 65 years or older. Case mortality due to dementia and
total mortality of the population by gender and age group
were derived from cause of death statistics from Statistics
Korea [21]. In Korea, the cause of death on the death cer-
tificate must, by law, be decided by a doctor. Therefore,
Korea has a relatively comprehensive and accurate death
certification system. The population structure of each gen-
der and age group in 2008 was derived from baseline popu-
lation estimates from Statistics Korea [16]. These datasets
from Statistics Korea are public data sources and com-
pletely open to the public with free website access [16,21].
Other parameters for the estimation of the burden of
disease, including incidence, disease duration, and age of
onset, were estimated with DISMOD-II software [22], using
prevalence, remission rate, case mortality, total population,
and total mortality. DISMOD II, developed by WHO for
the GBD project, is a software program that can be used to
estimate missing parameters and to verify the consistency
of the estimates for diseases [23]. The remission rate was as-
sumed to be zero. The disability weight of 0.911 was derived
from the results in the previous Korean panel study [24].
DALY calculation and projection
In general, this study followed the protocols of the original
GBD study [25]. DALYs are the sum of two components.
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of years lost when a person dies prematurely. The second
component, Years Lived with Disability measures the
number of years of healthy life lost due to temporary or
permanent disability. YLL estimates were derived from
mortality and life expectancy at birth in 2008 [26]. YLD
estimates were derived from incidence, mortality, disease
duration, and age of onset from the DISMOD II output.
YLL, YLD and DALY estimates were calculated according
to gender and 5-year age groups. We forecasted the
DALYs due to dementia in the years 2010–2050 by apply-
ing demographic structure projections and assuming a
constant age-specific prevalence of dementia [27].
Results
Results of DISMOD II modeling
Input variables in the DISMOD II model (prevalence, de-
mentia mortality, remission rate, population and overall
mortality) and output variables in the year 2008 generated
from the model are illustrated in Table 1. Comparing in-
put and output variables in terms of prevalence we did
not find any discrepancies; this implies consistency of esti-
mates for the diseases. Incidence demonstrated its peak at
the ages of 80–84 and subsequently decreased. Case mor-
tality showed a gradually increasing pattern in both gen-
ders. Incidence, prevalence, mortality, duration, and age of
onset outputs shown in Table 1 were used in the YLD cal-
culation. Mortality due to dementia from the DISMOD II
output was used in the YLL calculation.
YLLs, YLDs, and DALYs due to dementia
YLLs, YLDs, and DALYs in the year 2008 due to dementia
in the elderly in Korea were 24,344, 232,303, and 256,647
person-years, respectively (Table 2). The burden of demen-
tia was highest in the age group of 65–69 years (Table 2,
Figure 1). YLLs, YLDs, and DALYs due to dementia were
calculated per 100,000 in each age group and are listed in
Table 2 and Figure 2. In total, the YLLs, YLDs, and DALYs
in 2008 due to dementia per 100,000 were 50, 478, and 528
person-years, respectively. When projected to the general
population, the burden of disease due to dementia per
100,000 was 435 person-years in males and 622 person-
years in females in 2008. In the population aged 65 years
or older, the burden of dementia was 5,117 person-years
per 100,000 (males: 5,228 person-years, females: 5,041
person-years) in 2008.
DALYs due to dementia projected from the years 2010–2050
DALYs due to dementia projected from the years 2010 to
2050 are illustrated in Figure 3. In both males and females,
DALYs due to dementia were expected to show a continu-
ous increase. In 2050, DALYs due to dementia (814,629
person-years) are expected to be 3.0 times higher than
those in the year 2010 (274,849 person-years).Discussion
In this study, we estimated the burden of disease due to
dementia in Korea as 528 per 100,000, which accounts
for 4.5% of the total burden of disease in Korea in the
year 2008. WHO previously estimated the burden of dis-
ease due to dementia in Korea as 222 per 100,000 in the
year 2004 [28]. This accounted for 1.7% of the total bur-
den of disease in Korea which is less than half of the re-
sult reported in this study. This gap is derived from
differences in the epidemiologic data used in the studies.
The WHO study estimated the burden of dementia in
Korea based on the fact that Korea belongs to the West-
ern Pacific Regional Office (WPRO) B1, which includes
China [17]. The WHO study also used overall weighted
prevalence of dementia of 3.54% (male) and 4.45% (fe-
male) in calculating the DALYs in the WPRO B1 region.
However, the prevalence of dementia used in this study
was around 8.1% in 2008, which is also higher than the
results of another recent study in which the standardized
prevalence for adults aged 60 years and over is 6.3%)
[18]. As addressed in the methods section, the preva-
lence of dementia used in this study was derived from
the most recent study using a representative nationwide
sample of elderly Koreans [19]. In addition, Korea is one
of the most aged societies in the WPRO B1 region and
shows the most rapid rate of aging among developing
countries [29]. Previous studies have shown that the
prevalence of dementia among the elderly ranges from
3.6–11.9% in Western countries [30-36] and 4.8–7.2% in
Japan [37-40], which is a similar or lower prevalence
compared to that of Korea. These facts could explain
Korea’s high burden of dementia.
This study and the previous WHO study also differed in
their disability weight of dementia used in the DALY
calculation. In this study, we used the disability weight of
0.911, which was 1.46 times higher than the disability
weight of 0.625 used in the WHO study [17]. Whereas dis-
ability weights in the WHO study were greatly influenced
by developed Western countries, the disability weights in
this study were derived from a study conducted in Korea,
reflecting psychosocial circumstances specific to the coun-
try of study [24]. This gap, in part, explains the higher
DALY in this study compared with the WHO study.
Regarding the incidence and prevalence rates of
dementia used in the DALY calculation in this study,
increasing trends with increasing age in this study cor-
respond with previous study results. Several previous
studies [7,41,42] have reported that the doubling time of
incidence and prevalence of dementia was approximately
5 years. In this study, the incidence and prevalence of
dementia increased to almost double as age increased by
5 years, until the ages of 85–89 years. Above the age of
90 years, the rates of increase slowed and subsequently
decreased. In a previous study [8], the increasing
Table 1 Input and Output Variables in the DISMOD II Model (year 2008)
Age group Input Output
Prevalence‡ Dementia mortality * Population** Mortality* Incidence Prevalence Mortality Duration (yr) Age of onset (yr)
Men Women Men Women Men Women Men Women Men Women Men Women Men Women Men Women Men Women
65–69 0.0352 0.0307 0.0001 0.0001 829,526 987,096 0.0199 0.0077 0.0077 0.0062 0.0194 0.0171 0.0010 0.0003 12.61 16.69 67.85 67.85
70–74 0.0571 0.0436 0.0004 0.0003 610,634 825,685 0.0341 0.0150 0.0099 0.0078 0.0609 0.0517 0.0005 0.0003 10.99 13.73 72.45 72.44
75–79 0.1204 0.1152 0.0009 0.0010 345,459 590,729 0.0564 0.0298 0.0177 0.0135 0.1146 0.0936 0.0008 0.0008 8.20 10.06 77.85 77.86
80–84 0.2163 0.1628 0.0029 0.0031 163,459 345,906 0.0968 0.0585 0.0280 0.0278 0.2098 0.1759 0.0023 0.0025 6.32 7.46 82.43 82.64
85–89 0.2698 0.2871 0.0070 0.0077 65,151 167,598 0.1592 0.1087 0.0172 0.0303 0.2850 0.2787 0.0058 0.0067 5.29 5.73 87.13 87.31
90+ 0.2698 0.2871 0.0128 0.0153 17,951 66,832 0.2437 0.1992 0.0080 0.0108 0.2818 0.3064 0.0118 0.0143 4.53 3.87 99.71 97.06



















Table 2 YLL, YLD, and DALY due to Dementia in Korea (year 2008)
Age
group
Men Women Total Men (per 100,000 people) Women (per 100,000 people) Total (per 100,000 people)
YLL YLD DALY YLL YLD DALY YLL YLD DALY YLL YLD DALY YLL YLD DALY YLL YLD DALY
65–69 6,377 38,325 44,703 3,065 43,817 46,882 9,442 82,142 91,585 655 3,934 5,389 311 4,439 4,749 520 4,522 5,041
70–74 1,663 28,061 29,725 1,595 35,221 36,815 3,258 63,282 66,540 201 3,383 4,868 193 4,266 4,459 227 4,406 4,633
75–79 1,152 18,328 19,480 2,197 28,563 30,761 3,349 46,892 50,241 189 3,002 5,639 372 4,835 5,207 358 5,009 5,367
80–84 1,039 8,823 9,862 2,888 21,870 24,757 3,927 30,693 34,620 301 2,554 6,034 835 6,322 7,157 771 6,026 6,797
85–89 684 1,477 2,161 2,457 7,179 9,636 3,141 8,656 11,797 418 904 3,317 1,466 4,283 5,750 1,350 3,719 5,069
90+ 201 114 315 1,026 524 1,549 1,227 638 1,864 308 175 1,754 1,535 784 2,318 1,447 752 2,199
Total 11,116 95,130 106,246 13,228 137,174 150,401 24,344 232,303 256,647 46 390 435 55 567 622 50 478 528
65 ≤ 11,116 95,130 106,246 13,228 137,174 150,401 24,344 232,303 256,647 547 4,681 5,228 443 4,597 5,041 485 4,631 5,117



















Figure 1 YLL, YLD, and DALY due to dementia in Korea (2008). YLL: years of life lost, YLD: years lived with disability, DALY: disability-adjusted
life years.
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and reached a plateau in people aged 85 years and older.
This finding may relate to the difficulty in studying sam-
ples of individuals aged 90 years and older; the degree of
diagnostic difficulty increases with age. These findings
resulted in the increasing trend of DALY up to the age
of 80 years followed by a decrease in DALY. However,
even though we could not obtain an accurate level ofFigure 2 YLL, YLD, and DALY due to dementia in Korea (2008) (per 1
disability, DALY: disability-adjusted life years.incidence or prevalence of dementia in people aged 80–
90 years and older, the population in that age group is
relatively small; therefore a more accurate estimation of
DALYs due to dementia may not significantly influence
the overall figure.
The 274,849 DALYs due to dementia in 2010 will rise
to 814,629 DALYs in 2050, a 3.0-fold increase. This in-
crease could in part be explained by the rapidly aging00,000 in each age group). YLL: years of life lost, YLD: years lived with
Figure 3 DALYs due to dementia projected from the years 2010 to 2050 in Korea. DALY: disability-adjusted life years.
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veloping countries shall face a tremendous increase in
the burden due to dementia in the near future. Previous
reports have also forecasted that the burden of dementia
will become more serious in developing countries than
in developed countries because unprecedented declines
in mortality and fertility have resulted in a rapidly aging
population in most developing countries [8]. This fore-
cast provides us with important insight regarding health
and welfare service systems in developing countries. Previ-
ously, most developing countries have focused on commu-
nicable diseases and some chronic diseases as the major
health problems. These countries should now prepare to
manage diseases like dementia, which hamper the quality
of life and autonomy of older people. This will require the
redesign of national health and welfare service systems in
developing countries.
This study has several limitations. First, because of the
lack of more detailed epidemiologic information, we could
not distinguish the severity of dementia and, as such,
could not estimate DALYs according to disease severity
level. The resources needed to care for dementia patients
depend on the stage of the disease. Adult daycare pro-
grams may be adequate in the early stages, while a high
level of care, equivalent to that in nursing homes, will be
needed in the late stages [7]. Second, we could not distin-
guish the type of dementia, i.e., vascular dementia (VaD)
vs. Alzheimer's disease (AD). Even though there is a small
difference regarding the quality of life or autonomy due to
the type of dementia, the risk factors are different in eachtype, meaning different strategies for prevention are ne-
cessary. According to previous studies, the ratio of VaD to
AD has shown a wide variation, ranging from 1:1.5 – 1:7
according to the country. In Asian countries, the ratio of
VaD to AD is around 1:1.5. Most recent studies in Korea
have reported a ratio up to 1:3 [18,42], demonstrating that
the epidemiology of dementia in Korea is approaching
that of Western countries. These different types of demen-
tia might manifest as different levels of DALYs. However,
because VaD and AD share similar levels of deterioration
in quality of life and autonomy, the different types of de-
mentia should not impose substantial inaccuracies in the
DALY calculation. Third, in projecting the burden of
dementia, we assumed that the age-specific prevalence
of dementia would remain constant over time. In fact,
changes in risk exposure may increase or decrease the in-
cidence. Improved medical and social care might reduce
case mortality and increase prevalence. Interventions that
delay onset would have substantial potential for reducing
age-specific prevalence [7,29,43]. In light of these points,
the future burden of dementia is expected to be different
compared to that found in this study.
Despite these limitations, we believe that the detailed es-
timates contained in this paper provide the best currently
available basis for policymaking, planning, and allocation
of health and welfare resources for the management of de-
mentia. To tackle these problems, continuous monitoring
of the burden of disease due to dementia should be
conducted from this point forward. Raising awareness and
creating a framework for positive engagement between
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with dementia will be needed in the near future.
Conclusion
The burden of disease due to dementia in Korea is 528
per 100,000 population (males: 435, females: 622), and
5,117 per 100,000 in those over the age of 65 years (males:
5,228; females: 5,041). This accounts for 4.5% of the total
burden of disease in the year 2008. In the year 2050,
DALYs due to dementia (814,629) are expected to be 3.0
times higher than that in the year 2010 (274,849). This in-
dicates that Korea shall face a tremendous increase in the
burden due to dementia in the near future. This forecast
provides us with important insight regarding health and
welfare service systems in developing countries as well.
Redesign of national health and welfare service systems in
developing countries including Korea will be required in
the near future.
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